Quercetin Inhibits Proliferation and Drug Resistance in KB/VCR Oral Cancer Cells and Enhances Its Sensitivity to Vincristine

REFERENCES

• Shen SC, Chen YC, Hsu FL, and Lee WR: Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase-3 cascade. J Cell Biochem 89, 1044–1055, 2003.
   PubMed Web of Science ®Google Scholar
• Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, et al.: Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res 22, 1615–1627, 2002.
   PubMed Web of Science ®Google Scholar
• Choi JA, Kim JY, Lee JY, Kang CM, Kwon HJ, et al.: Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int J Oncol 19, 837–844, 2001.
   PubMed Web of Science ®Google Scholar
• Kawahara T, Kawaguchi-Ihara N, Okuhashi Y, Itoh M, Nara N, et al.: Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res 29, 4629–4632, 2009.
   PubMed Web of Science ®Google Scholar
• Chang YF, Hsu YC, Hung HF, Lee HJ, Lui WY, et al.: Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells. Nutr Cancer 61, 735–745, 2009.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhang K, Zhang Q, Mei J, Chen CJ, et al.: Effects of quercetin on the apoptosis of the human gastric carcinoma cells. Toxicol In Vitro 26, 221–228, 2012.
   PubMed Web of Science ®Google Scholar
• Biazevic MG, Antunes JL, Togni J, de Andrade FP, de Carvalho MB, et al.: Survival and quality of life of patients with oral and oropharyngeal cancer at 1-year follow-up of tumor resection. J Appl Oral Sci 18, 279–284, 2010.
   PubMed Web of Science ®Google Scholar
• Borowski E, Bontemps-Gracz MM, and Piwkowska A: Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells. Acta Biochim Pol 52, 609–627, 2005.
   PubMed Web of Science ®Google Scholar
• O’Connor R: The pharmacology of cancer resistance. Anticancer Res 27(3A), 1267–1272, 2007.
   PubMed Web of Science ®Google Scholar
• Gottesman MM: Mechanisms of cancer drug resistance. Annu Rev Med 53, 615–627, 2002.
   PubMed Web of Science ®Google Scholar
• Borska S, Sopel M, Chmielewska M, Zabel M, and Dziegiel P: Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin. Molecules 15, 857–870, 2010.
   PubMed Web of Science ®Google Scholar
• Bansal T, Awasthi A, Jaggi M, Khar RK, and Talegaonkar S: Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein. Life Sci 83(7–8), 250–259, 2008.
   PubMed Web of Science ®Google Scholar
• Lin CW, Shen SC, Hou WC, Yang LY, and Chen YC: Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9. Mol. Cancer Ther 7, 1195–1206, 2008.
   PubMed Web of Science ®Google Scholar
• Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254, 1976.
   PubMed Web of Science ®Google Scholar
• Xi GM, Sun B, Jiang HH, Kong F, Yuan HQ, et al.: Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity. Bioorg Med Chem 18, 6725–6733, 2010.
   PubMed Web of Science ®Google Scholar
• Yan YX, Li WZ, Huang YQ, and Liao WX: The COX-2 inhibitor Celecoxib enhances the sensitivity of KB/VCR oral cancer cell lines to Vincristine by down-regulating P-glycoprotein expression and function. Prostaglandins Other Lipid Mediat 97, 29–35, 2012.
   PubMed Web of Science ®Google Scholar
• Jordan RC and Daley T: Oral squamous cell carcinoma: new insights. J Can Dent Assoc 63, 517–518, 521–525, 1997.
   PubMedGoogle Scholar
• Hicks WL Jr., Loree TR, Garcia RI, Maamoun S, Marshall D, et al.: Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck 19, 400–405, 1997.
   PubMed Web of Science ®Google Scholar
• Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P, and Nagini S. The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer 63, 218–226, 2011.
   PubMed Web of Science ®Google Scholar
• Souto FO, Zarpelon AC, Staurengo-Ferrari L, Fattori V, Casagrande R, et al.: Quercetin reduces neutrophil recruitment induced by CXCL8, LTB4, and fMLP: inhibition of actin polymerization. J Nat Prod 74, 113–118, 2011.
   PubMed Web of Science ®Google Scholar
• Chan KC, Ho HH, Huang CN, Lin MC, Chen HM, et al.: Mulberry leaf extract inhibits vascular smooth muscle cell migration involving a block of small GTPase and Akt/NF-kappaB signals. J Agric Food Chem 57, 9147–9153, 2009.
   PubMed Web of Science ®Google Scholar
• Ishizawa K, Izawa-Ishizawa Y, Ohnishi S, Motobayashi Y, Kawazoe K, et al.: Quercetin glucuronide inhibits cell migration and proliferation by platelet-derived growth factor in vascular smooth muscle cells. J Pharmacol Sci 109, 257–264, 2009.
   PubMed Web of Science ®Google Scholar
• Ogasawara M, Matsunaga T, and Suzuki H: Differential effects of antioxidants on the in vitro invasion, growth and lung metastasis of murine colon cancer cells. Biol Pharm Bull 30(1), 200–204, 2007.
   PubMed Web of Science ®Google Scholar
• Shan BE, Wang MX, and Li RQ: Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 27, 604–612, 2009.
   PubMed Web of Science ®Google Scholar
• Yang JH, Hsia TC, Kuo HM, Chao PD, Chou CC, et al.: Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos 34, 296–304, 2006.
   PubMed Web of Science ®Google Scholar
• Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, et al.: Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Carcinogenesis 25, 1945–1952, 2004.
   PubMed Web of Science ®Google Scholar
• Ye B, Aponte M, Dai Y, Li L, Ho MC, et al.: Ginkgo biloba and ovarian cancer prevention:epidemiological and biological evidence. Cancer Lett 251, 43–52, 2007.
   PubMed Web of Science ®Google Scholar
• Zamin LL, Filippi-Chiela EC, Dillenburg-Pilla P, Horn F, Salbego C, et al.: Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci 100, 1655–1662, 2009.
   PubMed Web of Science ®Google Scholar
• Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281, 1322–1326, 1998.
   PubMed Web of Science ®Google Scholar
• Daniel PT: Dissecting the pathways to death. Leukemia 14, 2035–2044, 2000.
   PubMed Web of Science ®Google Scholar
• Lotem J and Sachs L: Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells. Cell Growth Differ 4, 41–47, 1993.
   PubMedGoogle Scholar
• Miyashita T and Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81, 151–157, 1993.
   PubMed Web of Science ®Google Scholar
• Aneja R, Zhou J, Zhou B, Chandra R, and Joshi HC: Treatment of hormone-refractory breast cancer: Apoptosis and regression of human tumors implanted in mice. Mol Cancer Ther 5, 2366–2377, 2006.
   PubMed Web of Science ®Google Scholar
• Bargou RC, Wagener C, Bommert K, Mapara MY, Daniel PT, et al.: Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J Clin Invest 97, 2651–2659, 1996.
   PubMed Web of Science ®Google Scholar
• Radetzki S, Köhne CH, von Haefen C, Gillissen B, Sturm I, et al.: The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene 21, 227–238, 2002.
   PubMed Web of Science ®Google Scholar
• Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, et al.: Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39, 361–398, 1991.
   Web of Science ®Google Scholar
• Gottesman MM, Fojo T, and Bates SE: Multidrug resistance in cancer: role of ATPdependent transporters. Nat Rev Cancer 2(1), 48–58, 2002.
   PubMed Web of Science ®Google Scholar
• Gottesman MM and Ling V: The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580, 998–1009, 2006.
   PubMed Web of Science ®Google Scholar
• Leonessa F and Clarke R: ATP binding cassette transporters and drug resistance in breast cancer. Endocr Relat Cancer 10, 43–73, 2003.
   PubMed Web of Science ®Google Scholar
• Formica JV and Regelson W: Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol 33, 1061–1080, 1995.
   PubMed Web of Science ®Google Scholar
• Kioka N, Hosokawa N, Komano T, Hirayoshi K, Nagata K, et al.: Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS Lett 301, 307–309, 1992.
   PubMed Web of Science ®Google Scholar
• Badhan R and Penny J: In silico modelling of the interaction of flavonoids with human P-glycoprotein nucleotide-binding domain. Eur J Med Chem; 41, 285–295, 2006.
   PubMed Web of Science ®Google Scholar
• Leslie EM, Deeley RG, and Cole SP: Multidrug resistance proteins: Role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204, 216–237, 2005.
   PubMed Web of Science ®Google Scholar
• Di Pietro A, Conseil G, Perez-Victoria JM, Dayan G, Baubichon-Cortay H, et al.: Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 59, 307–322, 2002.
   PubMed Web of Science ®Google Scholar
• Debes A, Oerding M, Willers R, Göbel U, and Wessalowski R: Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res 23, 3359–3366, 2003.
   PubMed Web of Science ®Google Scholar